phase readout
saveNCT02354014: Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB
RECRUITINGupdated 5d ago
community read0 votes
Sponsor: Janssen Research & Development, LLC. Phase: PHASE2. Conditions: Tuberculosis, Multidrug-Resistant
view source ↗
comments(0)
5-min edit window · permanent after that